TCM
XENT

Tamarack Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Tamarack Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,149
Closed -$337K – 48
2014
Q4 		$337K Buy
+18,149
New +$327K 0.05% 39

Other funds holding XENT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Tamarack Capital Management's XENT Position: Q1 2015 in Review

Tamarack Capital Management sold out of Intersect ENT, Inc (XENT) in Q1 2015, closing a stake of 18,149 shares — an estimated $337K sold.

Tamarack Capital Management first reported a position in XENT in Q4 2014 and held it in 1 quarter. The position peaked at $337K in Q4 2014. 97 funds tracked by Wall St. Rank hold XENT as of Q1 2015.

  • Tamarack Capital Management reported no remaining Intersect ENT, Inc position as of Q1 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 18,149 Intersect ENT, Inc shares in Q1 2015, an estimated $337K.
  • Tamarack Capital Management first reported a position in Intersect ENT, Inc in Q4 2014 and held it in 1 quarter.
  • Tamarack Capital Management's Intersect ENT, Inc position peaked at $337K in Q4 2014.
  • 97 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2015.

Based on Tamarack Capital Management's 13F filing for Q1 2015, filed 11 May 2015.